Back to 
PRICE T ROWE ASSOCIATES INC /MD/
PRICE T ROWE ASSOCIATES INC /MD/
AKTS2 quarters
Position history for PRICE T ROWE ASSOCIATES INC /MD/'s holdings in AKTIS ONCOLOGY INC
Yes. Price T Rowe Associates holds 763,499 shares of AKTS (Aktis Oncology), worth $24.6M, as of its Q2 2026 13F filing. It reduced the position by 800,697 shares (-51.2%) from Q1 2026. Price T Rowe Associates has held AKTS in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$24.6M
Current Shares
763,499
Total Value Change
-$3.4M
Total Shares Change
-800,697
Quarter-by-Quarter History
Other major holders of AKTS: BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., Jupiter Topco LLC